Cytokinetics, Inc. (CYTK)
72.13
-5.77
(-7.41%)
USD |
NASDAQ |
Aug 28, 16:00
72.11
-0.02
(-0.03%)
After-Hours: 18:34
Cytokinetics Total Return Price : 72.13 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 77.90 |
| August 26, 2026 | 79.20 |
| August 25, 2026 | 77.46 |
| August 24, 2026 | 77.09 |
| August 21, 2026 | 76.84 |
| August 20, 2026 | 77.18 |
| August 19, 2026 | 77.74 |
| August 18, 2026 | 76.10 |
| August 17, 2026 | 75.87 |
| August 14, 2026 | 74.13 |
| August 13, 2026 | 73.45 |
| August 12, 2026 | 75.64 |
| August 11, 2026 | 76.45 |
| August 10, 2026 | 77.49 |
| August 07, 2026 | 76.76 |
| August 06, 2026 | 81.37 |
| August 05, 2026 | 78.85 |
| August 04, 2026 | 78.61 |
| August 03, 2026 | 76.45 |
| July 31, 2026 | 77.13 |
| July 30, 2026 | 80.42 |
| July 29, 2026 | 78.38 |
| July 28, 2026 | 79.45 |
| July 27, 2026 | 80.62 |
| July 24, 2026 | 80.74 |
| Date | Value |
|---|---|
| July 23, 2026 | 81.92 |
| July 22, 2026 | 82.19 |
| July 21, 2026 | 81.11 |
| July 20, 2026 | 79.11 |
| July 17, 2026 | 80.18 |
| July 16, 2026 | 80.36 |
| July 15, 2026 | 82.62 |
| July 14, 2026 | 81.93 |
| July 13, 2026 | 82.24 |
| July 10, 2026 | 84.87 |
| July 09, 2026 | 86.07 |
| July 08, 2026 | 84.88 |
| July 07, 2026 | 85.56 |
| July 06, 2026 | 85.57 |
| July 02, 2026 | 86.49 |
| July 01, 2026 | 85.26 |
| June 30, 2026 | 85.19 |
| June 29, 2026 | 87.26 |
| June 26, 2026 | 82.19 |
| June 25, 2026 | 80.80 |
| June 24, 2026 | 81.20 |
| June 23, 2026 | 80.01 |
| June 22, 2026 | 79.17 |
| June 18, 2026 | 78.78 |
| June 17, 2026 | 78.11 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Krystal Biotech, Inc. | 351.55 |
| Ionis Pharmaceuticals, Inc. | 61.05 |
| Bristol Myers Squibb Co. | 66.57 |
| Gilead Sciences, Inc. | 145.70 |
| Rigel Pharmaceuticals, Inc. | 46.52 |